silmitasertib: Clinical Trials

6 trials of silmitasertib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 1 recruiting. 6 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 3, Completed 2, Recruiting 1
Phase 13Completed 1, Recruiting 1, Terminated 1

Follow silmitasertib: new trials by email Literature Review of silmitasertib trials Research Report on silmitasertib

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Silmitasertib, Irinotecan, Temozolomide - Neuroblastoma, Ewing Sarcoma
Phase 1 / Phase 2RecruitingMilton S. Hershey Medical Center1042024-10-302026-11-12
CX-4945 in Viral Community Acquired Pneumonia
CX-4945 (SARS-CoV-2 domain), Placebo (SARS-CoV-2 domain), CX-4945 (Influenza virus domain) - Community-acquired Pneumonia, SARS-CoV-2 -Associated Pneumonia
Phase 2TerminatedSenhwa Biosciences, Inc.452024-03-202026-01-08
Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)
Silmitasertib - Coronavirus
Phase 2TerminatedUniversity of Arizona312021-01-212023-11-07
Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19
Silmitasertib, SOC - Covid19
Phase 2CompletedSenhwa Biosciences, Inc.202020-11-302025-01-16
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
CX 4945 - Medulloblastoma, Childhood, Medulloblastoma Recurrent
Phase 1 / Phase 2TerminatedPediatric Brain Tumor Consortium212019-07-252026-10-19
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
CX-4945, Cisplatin, Gemcitabine - Cholangiocarcinoma
Phase 1 / Phase 2CompletedSenhwa Biosciences, Inc.1272014-06-012021-10-22

Conditions studied

COVID-19 (3)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Cholangiocarcinoma (1)  ·  Community-Acquired Pneumonia (1)  ·  Coronavirus Infections (1)  ·  Influenza, Human (1)  ·  Liposarcoma (1)  ·  Medulloblastoma (1)  ·  Microphthalmia, Isolated, with Coloboma 5 (1)  ·  Neuroblastoma (1)  ·  Osteosarcoma (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma, Ewing (1)

Sponsors

Senhwa Biosciences, Inc. (3)  ·  Milton S. Hershey Medical Center (1)  ·  Pediatric Brain Tumor Consortium (1)  ·  University of Arizona (1)

Countries

United States (5)  ·  Taiwan (2)  ·  Canada (1)  ·  South Korea (1)

Top investigators

Chandrika Behura, MD (1)  ·  Chris P. Recknor, MD (1)  ·  Jason Huang, M.D. (1)  ·  Mitesh Borad, M.D. (1)  ·  Ralph Salloum, MD (1)

NIH funding

UM1CA081457 (1)